$PFE (-0,63%) has announced that it will sell its stake in $BNTX (-1,6%) and to sell 4.5 million shares in order to better finance the, in my view, totally overpriced panic takeover of $MTSR better financed. The collaboration with $BNTX (-1,6%) in the area of corona vaccines is to remain in place. In the medium term, I see $BNTX (-1,6%) positive. Should $PFE (-0,63%) times with $LLY (-2,35%) and $NOVO B (-0,34%) more about obesity patients.
MTS
Metsera, Inc.
Azione
Azione
Ticker: MTSR
MTSR
Price
Discussione su MTSR
Messaggi
3
11Mes·
Out of Novo and Paypal
update***
I fired to fast after reading the earnings call summary. After getting into it a bit more, this would be a wait and see for me. Theybuodated data from their orsl drugc and its approval would put them in a pole position for oral diabetes and weight loss treatment and sentiment might change… they would be first, and for now it seems that it is more efective than $LLY (-2,35%) candidate. It was more of a “hold” rather than a “sell”.
If I have the option of reentering at a lower level, I might.
——————
After cutting again its sales and earnings forecast, I’m out of $NOVO B (-0,34%)
I saw as an oportunity its decline and “low” valuation, and as an exagerated market’s reaction when they cut their previous forecasts… Now I think I was wrong.
They’re defenetely not performing well in a market that is growing fast. I take the fact that they’re going after $MTSR is another sign of desperation, and them lowering guidance again tells me they are either lost, or trying to hold the stock by not telling what they know at once.
If they can’t meet their own expectations now, when this market becomes even more competitive they’ll have a big problem… so I’m out.
I’m also selling $PYPL (-0,46%) I still think the market is wrong on this one, but I’ll use this sell to lower my profits a bit. I might buy back in a couple months if the valuation is still the same.
11
1Anno·
Billion-euro investment in the pharmaceutical industry Pfizer apparently about to take over weight loss specialist Metsera
The US pharmaceutical giant has so far had little success with the development of its own slimming product. According to a media report, it is now set to enter the market in a different way.
According to a newspaper report, the pharmaceutical group Pfizer is on the verge of acquiring the US company Metsera, which specializes in weight loss drugs. As the "Financial Times" reported, citing unnamed sources, the takeover with a volume of up to 7.3 billion dollars could be announced as early as Monday. Pfizer and Metsera were initially unavailable for comment.
According to the report, Pfizer wants to pay 47.50 dollars per Metsera share in cash. In addition, a further 22.50 dollars per share would be linked to the achievement of certain targets. The bid of 47.50 dollars per share corresponds to a premium of more than 40 percent on Metsera's closing price on Friday. At that time, the company had a market capitalization of around 3.5 billion dollars.
With the acquisition, Pfizer wants to secure a place in the lucrative market for weight loss drugs. The company had suffered setbacks in the development of its own drugs. Work on an experimental weight loss pill called Danuglipron was abandoned in April after a mid-stage study showed poor tolerability. A single daily dose version that was later tested on 1,400 patients raised concerns about effects on the liver.
Metsera was founded in 2022 and celebrated a brilliant debut on the US technology exchange Nasdaq in January. The company's most advanced drug candidate in development, MET-097i, showed an average weight loss of 11.3 percent in a mid-stage trial, according to the company.
The demand for weight loss drugs is growing rapidly, with competitors Eli Lilly and Novo Nordisk battling for market leadership. Some experts predict that the global market for weight loss drugs could reach a value of 150 billion dollars by the early 2030s.
1111
1 Commento
Pfizer is nice and cheap at the moment with a high dividend. Buy more at the end of the month. Pfizer will not go bankrupt... 😋
•
22
•